CHRS

Coherus BioSciences (CHRS)

About Coherus BioSciences (CHRS)

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Details

Daily high

$1.54

Daily low

$1.40

Price at open

$1.44

52 Week High

$3.70

52 Week Low

$0.66

Market cap

175.1M

Dividend yield

0.00%

Volume

4.3M

Avg. volume

10.4M

P/E ratio

-15.09

Coherus BioSciences News